Quest Q2 2026 EPS up 19.1% as revenues jump 10.2%
Quest Diagnostics reported double-digit revenue and EPS growth in the second quarter and raised its full-year guidance, driven by organic growth and strong demand for diagnostic services.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day